Fasenra is manufactured in the USA. It is shipped cold chain from India by courier and the price includes all costs.
Information about Fasenra (Benralizumab)
Fasenra is a monoclonal antibody used in the treatment of severe asthma and other eosinophilic conditions. It works by targeting and depleting eosinophils, a type of white blood cell that plays a key role in inflammation.
Product Highlights
- For patients whose asthma remains uncontrolled despite standard treatment.
- Eosinophilic Granulomatosis with Polyangiitis (EGPA) as an add-on treatment for this rare disease.
- Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) In adults with this condition.
Key Ingredient
Key Benefits
- Significantly decreases eosinophil levels, leading to reduced inflammation.
- Clinical studies show improved lung function and reduced exacerbations.
- Generally well-received in terms of safety and side effects.
Direction of Use
- Fasenra is administered via subcutaneous injection.
- Typically by a healthcare professional, though some patients may be trained to self-administer after the initial doses.
Safety Concerns
- Injection site reactions, headache, and fatigue.
- Risk of serious allergic reactions (anaphylaxis), and potential for infections due to immune modulation.
- Regular monitoring for eosinophil levels and signs of infection is recommended.
Avoid Fasenra (Benralizumab) If
- You have a known hypersensitivity to benralizumab or any component of the formulation.
- You have active or uncontrolled infections.
- You are pregnant or breastfeeding without prior consultation with a healthcare provider.
This product requires special packaging to maintain its integrity during the shipping process. DO NOT USE THIS MEDICATION if the attached temperature indicator shows that the medication was exposed to temperatures below 2 degrees or above 8 degrees Celsius, and contact the pharmacy immediately.
